Literature DB >> 12559621

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

Sven Becker1, Torsten Tonn, Tobias Füssel, Markus Uhrberg, Manuela Bogdanow, Erhard Seifried, Christian Seidl.   

Abstract

Natural killer (NK) cell-mediated cytolysis is stimulated and downregulated through the interaction of distinct human leukocyte antigen (HLA) class I molecules on target cells with specific killer cell immunoglobulinlike receptors (KIRs) on NK cells. Killer cell immunoglobulinlike receptors are highly polymorphic and are clonally distributed on NK cell populations within individuals. However, the regulation of KIR expression by individual HLA class I phenotypes is not well understood. To examine a potential influence of the HLA class I phenotype on KIR expression patterns we studied the KIR expression in individuals that were subgrouped according to the major HLA-C encoded KIR-epitopes (group C1 versus C2). In these individuals, NK cells were analyzed for KIR expression using flow cytometry and RNA-based expression analysis. Our results demonstrate that KIR genes are transmitted very heterogeneously with two main patterns of KIR genotypes as previously described; group A and group B (with 21 different genotypes). There are distinct populations exhibiting different densities of CD158a and/or CD158b positive NK cells that coexist in all individuals. A clear correlation between KIR expression and the currently known HLA class I ligands was not observed. In conclusion, the surface expression of KIRs in individuals with different HLA class I genotypes indicates that other non-HLA class I encoded factors contribute to the shaping of the KIR repertoire.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559621     DOI: 10.1016/s0198-8859(02)00802-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

2.  The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions.

Authors:  Giuseppe Sconocchia; Michelle Lau; Maurizio Provenzano; Katayoun Rezvani; Wachanan Wongsena; Hiroshi Fujiwara; Nancy Hensel; Jos Melenhorst; Jonming Li; Soldano Ferrone; A John Barrett
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

Review 3.  Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged.

Authors:  Abbe N Vallejo
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2.

Authors:  Wei Wang; Amy K Erbe; Mikayla Gallenberger; KyungMann Kim; Lakeesha Carmichael; Dustin Hess; Eneida A Mendonca; Yiqiang Song; Jacquelyn A Hank; Su-Chun Cheng; Sabina Signoretti; Michael Atkins; Alexander Carlson; Jonathan M Weiss; James Mier; David Panka; David F McDermott; Paul M Sondel
Journal:  Cancer Immunol Immunother       Date:  2016-09-30       Impact factor: 6.968

5.  IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.

Authors:  Claudia Brehm; Sabine Huenecke; Andrea Quaiser; Ruth Esser; Melanie Bremm; Stephan Kloess; Jan Soerensen; Hermann Kreyenberg; Christian Seidl; Petra S A Becker; Heiko Mühl; Thomas Klingebiel; Peter Bader; Jakob R Passweg; Dirk Schwabe; Ulrike Koehl
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

6.  Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population.

Authors:  A Bontadini; M Testi; M C Cuccia; M Martinetti; C Carcassi; A Chiesa; E Cosentini; E Dametto; S Frison; A M Iannone; C Lombardo; A Malagoli; M Mariani; L Mariotti; L Mascaretti; L Mele; V Miotti; S Nesci; G Ozzella; D Piancatelli; G Romeo; C Tagliaferri; S Vatta; M Andreani; R Conte
Journal:  J Transl Med       Date:  2006-10-27       Impact factor: 5.531

7.  KIR and HLA haplotype analysis in a family lacking the KIR 2DL1-2DP1 genes.

Authors:  S Vojvodić; D Ademović-Sazdanić
Journal:  Balkan J Med Genet       Date:  2015-12-30       Impact factor: 0.519

8.  Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol.

Authors:  Ulrike Koehl; Claudia Brehm; Sabine Huenecke; Stefanie-Yvonne Zimmermann; Stephan Kloess; Melanie Bremm; Evelyn Ullrich; Jan Soerensen; Andrea Quaiser; Stephanie Erben; Claudia Wunram; Tanja Gardlowski; Eileen Auth; Torsten Tonn; Christian Seidl; Sandrine Meyer-Monard; Martin Stern; Jakob Passweg; Thomas Klingebiel; Peter Bader; Dirk Schwabe; Ruth Esser
Journal:  Front Oncol       Date:  2013-05-17       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.